Let Cognitive Decline Concern Get Flushed out with Alzheimer Treatment
The bankruptcy of the Medicare system is not too far as it is projected to happen by 2050 when the Cognitive decline reaches the final point. Alzheimer is a condition when the brain does not work properly. However, the situation is not the same as brain impairment, which is a sign of damage. This problem is due to natural processes such as aging. In short, this is a stage between expected cognitive decline due to aging and a more serious decline of Dementia.
Let’s unveil this problem in detail
Cognitive decline is more or less a kind of disorder than occur subtly in the brain without letting human aware of it. It starts slowly and steadily without letting the person know about it and progress unless & until it impedes the quality of life and reaches the point of Dementia. The disorder is of various types, and it’s important to understand the same through cognitive dysfunction.
In medical terms, we can say that cognitive disorders are a part of the neurocognitive disease in the fifth part of the diagnostic and statistical manual of mental disorders (DSM-V)
Why is Cognitive Decline Essential to be treated at the Earliest?
It’s essential to get started with cognitive decline treatment at the right time. Though it is an aging problem with indications like changes in memory, language, thinking, and judgment; it should not be ignored as the mild cognitive impairment has a huge probability of Dementia in the later stages if not checked and treated on time.
Here are certain facts that show why cognitive decline problem should be taken seriously:
“Cognitive decline is a major concern of the aging population, and Alzheimer’s disease is the major cause of age-related cognitive decline, with approximately 5.4 million American patients and 30 million affected globally. In the absence of effective prevention and treatment, the prospects for the future are of great concern, with 13 million Americans and 160 million globally projected for 2050, leading to potential bankruptcy of the Medicare system. Unlike several other chronic illnesses, Alzheimer’s disease prevalence is on the rise, which makes the need to develop effective prevention and treatment increasingly pressing. Recent estimates suggest that AD has become the third leading cause of death in the United States.”
Symptoms and Causes of Cognitive Decline
Though there are symptoms and causes of cognitive decline, it’s important to understand it clearly and get set for the essential treatment which can prevent your brain from inching slowly towards the condition of Dementia.
A person feels himself/herself in a dilemma while taking any action
Losing coordination with sense organs
Short /long term memory loss
Abnormal clumps of beta-amyloid protein are the indications of Alzheimer's disease
Small Strokes or reduced blood flow through the brain blood vessels.
Risk Factors and Lifestyle Changes Involved with Cognitive Decline
Here are certain risk factors involved with growing cognitive decline issues:
Huge prospects of Type-2 diabetes
Blood pressure problems
Increase in LDL cholesterol level
Anxiety and Depression
Lack of workout
Medication for Cognitive Decline Problem
You’re quite fortunate that there is an option available to treat cognitive decline. Though this problem cannot be cured permanently, the symptoms can be treated, which can help in the improvement of your life. The therapeutic success can be quite effective by all means as it improves the condition of a person to a huge extent without any side effects.
Here are some medical facts associated with the treatment of Cognitive Decline:
“Therapeutic success for other chronic illnesses such as cardiovascular disease, cancer, and HIV, has been improved through the use of combination therapies. In the case of AD and its predecessors, mild cognitive impairment (MCI) and subjective cognitive impairment (SCI), comprehensive combination therapies have not been explored. However, the past few decades of genetic and biochemical research have revealed an extensive network of molecular interactions involved in AD pathogenesis, suggesting that a network-based therapeutics approach, rather than a single target-based approach, may be feasible and potentially more effective for the treatment of cognitive decline due to Alzheimer’s disease.”